These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6571195)

  • 1. Experiences with tobramycin in polyresistant bacterial urological infections.
    Zarándy B; Varga G
    Ther Hung; 1984; 32(3):123-6. PubMed ID: 6571195
    [No Abstract]   [Full Text] [Related]  

  • 2. Tobramycin in the treatment of severe and complicated urinary tract infections.
    Bailey RR; Peddie B
    N Z Med J; 1976 Jul; 84(567):1-3. PubMed ID: 823477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tobramycin. Bacteriological studies and clinical activity in urinary and extra-urinary infections].
    Abbate GF; Alagia I; Gattoni A; Leonessa V; Manguso L; Altucci P
    G Ital Chemioter; 1977; 24(1-2):33-7. PubMed ID: 615760
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of tobramycin in single daily doses in urological surgery].
    Tigano G; Andrisani C
    Minerva Urol; 1983; 35(2):149-52. PubMed ID: 6633477
    [No Abstract]   [Full Text] [Related]  

  • 5. [The etiological structure of the causative agents of inflammatory nonspecific urological diseases and the dynamics of their resistance to the widely used antibiotics].
    Derevianko NI; Kotliarova GA; Kondrat'eva EM; Nefedova LA; Kudriashova EE
    Urol Nefrol (Mosk); 1997; (3):13-8. PubMed ID: 9245048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brulamycin in the treatment of urinary infections--microbiological and clinical research].
    Minkov N; Zlatanov Z; Zozikov E; Staneva D; Krusheva R
    Vutr Boles; 1984; 23(5):54-9. PubMed ID: 6395493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested].
    Alegente G; Marchi B; Pieri I; Saturni A; Progenie G; Rubino M
    Quad Sclavo Diagn; 1983 Sep; 19(3):343-8. PubMed ID: 6677931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tobramycin in pediatrics. Report of 24 cases].
    Fournet JP; Huault G; Castaing H; Mariel C
    Ann Pediatr (Paris); 1976 Apr; 23(4):293-9. PubMed ID: 16104222
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of urinary tract infections with the antibiotic tobramycin].
    Osten J; Cejková J
    Vnitr Lek; 1979 Oct; 25(10):989-94. PubMed ID: 516482
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of urinary tract infections with ciprofloxacin].
    Horcicková M; Prát V; Matousovic K; Hatala M; Liska M; Milotová Z
    Cas Lek Cesk; 1987 Sep; 126(39):1221-4. PubMed ID: 3664597
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of tobramycin in the treatment of urinary infections].
    Socquet Y
    Acta Urol Belg; 1977 Jul; 45(3):282-8. PubMed ID: 899982
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activity of gentamicin on some bacterial species responsible for urinary tract infections. Clinical and bacteriological results].
    Di Grazia G; Pisano A
    G Ital Chemioter; 1969; 16(1):105-9. PubMed ID: 5404082
    [No Abstract]   [Full Text] [Related]  

  • 13. Tobramycin once-a-day vs cefoperazone twice-a-day in the therapy of urinary tract infections.
    Bonadio M; Maccanti O; Cosci S; Benvenuti S
    J Chemother; 1989 Jul; 1(4 Suppl):860-1. PubMed ID: 16312673
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary pathogenic bacteria in general practice. Incidence and antibiotic resistance].
    Digranes A; Dibb WL; Benonisen E
    Tidsskr Nor Laegeforen; 1983 May; 103(14):1183-6. PubMed ID: 6879554
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sensitivity tests of 260 bacterial strains isolated from urinary tract infections].
    Zhonghua Yi Xue Za Zhi; 1974 Sep; (9):558-62, 159. PubMed ID: 4214372
    [No Abstract]   [Full Text] [Related]  

  • 16. [Single-dose tobramycin in the therapy and prevention of urinary infections].
    Trombetta C; Belgrano E; Puppo P
    Minerva Urol; 1983; 35(4):291-4. PubMed ID: 6674753
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with cefmetazole in the urological field].
    Aga Y; Yano M; Ogura K
    Hinyokika Kiyo; 1983 Apr; 29(4):459-63. PubMed ID: 6587763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriological and clinical experiences with ofloxacin in urinary tract infections.
    Fröhlich G; Stratmeyer R
    Chemioterapia; 1987 Jun; 6(2 Suppl):525-6. PubMed ID: 3509489
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical bacteriology of tobramycin.
    McAllister TA
    Scott Med J; 1976 Apr; 21(2):64-6. PubMed ID: 940995
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modification of the rapid electrochemical micromethod for resistance determination in urinary tract infections].
    Stradtmann H; Schauer O
    Z Med Lab Diagn; 1980; 21(4):242-3. PubMed ID: 7467688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.